In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Titel:
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Auteur:
Martinez-Turrillas, Rebeca Martin-Mallo, Angel Rodriguez-Diaz, Saray Zapata-Linares, Natalia Rodriguez-Marquez, Paula San Martin-Uriz, Patxi Vilas-Zornoza, Amaia Calleja-Cervantes, María E. Salido, Eduardo Prosper, Felipe Rodriguez-Madoz, Juan R.